Oct 2, 2026 06:04AM
Oct 2, 2026 02:30AM
Sep 28, 2026 05:33PM
Sep 28, 2026 05:30PM
Sep 17, 2026 06:00AM
Aug 5, 2026 08:31AM
Aug 5, 2026 08:14AM Exclusive-'No discussions' over AstraZeneca-Bristol Myers deal, senior source says
Aug 3, 2026 11:24AM
Aug 3, 2026 08:17AM
Aug 3, 2026 05:50AM
Jul 27, 2026 07:00AM
Jul 14, 2026 05:52AM
May 18, 2026 07:00AM
May 18, 2026 07:00AM BAXFENDY approved in the US as the first and only aldosterone synthase inhibitor treatment for adults with hypertension
Apr 29, 2026 07:00AM
Apr 27, 2026 07:03AM
Apr 27, 2026 07:00AM
Feb 10, 2026 07:00AM
Jan 13, 2026 02:50PM
Dec 2, 2025 09:18AM
Dec 2, 2025 09:18AM Baxdrostat New Drug Application accepted under FDA Priority Review in the US for patients with hard-to-control hypertension
Nov 10, 2025 02:31AM
Nov 9, 2025 04:33PM
Nov 6, 2025 07:02AM
Nov 6, 2025 07:00AM
Nov 6, 2025 07:00AM
Oct 7, 2025 07:00AM
Oct 7, 2025 07:00AM Baxdrostat met the primary endpoint in Bax24 Phase III trial in patients with resistant hypertension
Sep 17, 2025 07:06AM
Sep 17, 2025 07:05AM
Sep 17, 2025 06:49AM
Aug 30, 2025 10:19AM
Jul 29, 2025 07:00AM
Jul 14, 2025 07:01AM
Jul 14, 2025 07:00AM Baxdrostat met the primary and all secondary endpoints in BaxHTN Phase III trial in patients with uncontrolled or treatment resistant hypertension
May 29, 2025 04:30PM
May 29, 2025 04:30PM
Apr 29, 2025 02:00AM
Mar 21, 2025 07:22AM
Mar 17, 2025 08:14AM
Feb 6, 2025 07:00AM
Jan 23, 2025 02:18PM AstraZeneca (AZN) plans C$820 million (US$570m) investment in Canada to advance growing global hub and clinical delivery
Jan 22, 2025 08:30AM
Dec 24, 2024 09:30AM
Nov 12, 2024 07:00AM
Jul 25, 2024 07:00AM
Jul 25, 2024 05:25AM
Jul 15, 2024 05:55AM
Jun 4, 2024 04:18PM AstraZeneca (AZN) Completes Acquisition of Fusion Pharmaceuticals
May 30, 2024 07:07AM

1,194,874 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All